Bertrand, Julian <br/><br/>
Cyclooxygenase-2 positively regulates Akt signalling and enhances survival of erythroleukemia cells exposed to anticancer agents.  [electronic resource] 

 -  Apoptosis : an international journal on programmed cell death  Jul 2013 
 - 836-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-675X 
<br/><br/><label>Standard No.: </label>10.1007/s10495-013-0825-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Arsenic Trioxide<br/>Arsenicals--pharmacology<br/>Casein Kinase II--genetics<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cyclooxygenase 2--genetics<br/>Etoposide--pharmacology<br/>Fluorouracil--pharmacology<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Leukemia, Erythroblastic, Acute--genetics<br/>Oxides--pharmacology<br/>PTEN Phosphohydrolase--genetics<br/>Proto-Oncogene Proteins c-akt--genetics<br/>RNA, Small Interfering--genetics<br/>Signal Transduction<br/>Staurosporine--pharmacology